ARKK Daily Position Changes Report: June 5, 2026 to June 6, 2026
Overview
On June 6, 2026, the ARK Innovation ETF (ARKK) made notable adjustments to its holdings, reflecting strategic shifts in its investment portfolio. The most significant trade was the reduction in the position of Tesla Inc (TSLA), which saw a decrease in both share value and portfolio weight.
Detailed Summary
- Tesla Inc (TSLA): ARKK sold shares, resulting in a decrease in its portfolio weight from 10.4697% to 10.0998%. The estimated trade value for this reduction was approximately $717,498,221.65, marking a significant shift.
- Advanced Micro Devices Inc (AMD): The weight decreased from 5.5751% to 4.8736%, indicating a reduction in holdings with an estimated trade value of $346,228,646.40.
- CRISPR Therapeutics AG (CRSP): The weight increased from 4.7999% to 5.1268%, suggesting a strategic buy with a trade value of $364,215,239.45.
- Tempus AI Inc-A (TEM): The weight increased from 4.7236% to 5.0752%, reflecting a buy with an estimated trade value of $360,546,025.32.
- Robinhood Markets Inc-A (HOOD): The weight increased from 4.5584% to 4.6935%, indicating a buy with an estimated trade value of $333,434,002.11.
Position Changes Summary Table
| Ticker | Company Name | Direction | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|
| TSLA | Tesla Inc | Sell | $717,498,221.65 | -0.3699% |
| AMD | Advanced Micro Devices Inc | Sell | $346,228,646.40 | -0.7015% |
| CRSP | CRISPR Therapeutics AG | Buy | $364,215,239.45 | +0.3269% |
| TEM | Tempus AI Inc-A | Buy | $360,546,025.32 | +0.3516% |
| HOOD | Robinhood Markets Inc-A | Buy | $333,434,002.11 | +0.1349% |
| SHOP | Shopify Inc-A | No Change | - | 0.0000% |
| ROKU | Roku Inc-A | No Change | - | 0.0000% |
| CRCL | - | No Change | - | 0.0000% |
| COIN | Coinbase Global Inc-A | No Change | - | 0.0000% |
| TWST | Twist Bioscience Corp | No Change | - | 0.0000% |
Analysis and Interpretation
The trading activity on June 6, 2026, indicates a strategic shift by ARKK, particularly with the significant reduction in Tesla's position, which may reflect a reevaluation of its growth prospects amid market fluctuations. The increase in holdings for CRISPR Therapeutics and Tempus AI suggests a bullish outlook on biotech and AI sectors, aligning with ARK's focus on innovation and disruptive technologies. Overall, these position changes highlight ARK's active management style and responsiveness to market dynamics.
This report will be updated with weekly summaries on Saturdays, reflecting cumulative changes and broader market context.
Explore more exclusive insights at nextfin.ai.
